Table 2.
Relationship of Opioid Use to Demographic Factors, Gastric Emptying, and Resource Utilization
Category | Variable | On opioids | Not on opioids | P value, on vs not on opioids | On potent opioids | On weaker opioids | P value, on potent vs weaker opioids |
---|---|---|---|---|---|---|---|
Demographic factors | Age, y, means ± SD | 44 ± 13 | 42 ± 14 | .11 | 44 ± 13 | 44 ± 13 | .95 |
Female sex | 202/240 (84%) | 286/343 (83%) | .80 | 165/198 (83%) | 37/42 (88%) | .64 | |
Race | |||||||
White | 84% | 89% | .18 | 84% | 86% | .87 | |
Black | 12% | 8% | 12% | 10% | |||
Other | 4% | 3% | 4% | 5% | |||
Etiology | |||||||
Diabetic | 38% | 32% | .13 | 39% | 31% | .39 | |
Idiopathic | 62% | 68% | 61% | 69% | |||
Pain severity | PAGI-SYM upper abdominal pain score ≥ 3 | 180/240 (75%) | 205/343 (60%) | .0001 | 155/198 (78%) | 25/42 (60%) | .02 |
PAGI-SYM upper abdominal pain score <3 | 60/240 (25%) | 138/343 (40%) | 43/198 (22%) | 17/42 (40%) | |||
Gastric emptying measures | 4-hour solid retention, means ± SD | 36% ± 22% | 32% ± 20% | .008 | 37% ± 23% | 33% ± 18% | .28 |
4-hour solid retention severity | |||||||
Mild, 10%–20% retained | 29% | 38% | .02 | 29% | 29% | .17 | |
Moderate, 20%–35% retained | 29% | 31% | 27% | 40% | |||
Severe, >35% retained | 42% | 31% | 44% | 31% | |||
2-hour solid retention, means ± SD | 65% ± 19% | 64% ± 18% | .53 | 65% ± 19% | 65% ± 18% | .89 | |
1-hour liquid retention, means ± SD | 49% ± 17% | 50% ± 17% | .73 | 48% ± 19% | 50% ± 12% | .75 | |
Health resource utilization | Hospitalized for gastroparesis in past year | 131/240 (55%) | 123/343 (36%) | <.0001 | 114/198 (58%) | 17/42 (40%) | .06 |
Hospitalizations per year, means ± SD | 3.3 ± 5.5 | 1.5 ± 4.2 | <.0001 | 3.6 ± 5.7 | 1.8 ± 3.8 | .01 | |
Medication use | |||||||
Prokinetics | 129/240 (54%) | 182/343 (53%) | .87 | 106/198 (54%) | 23/42 (55%) | 1.00 | |
Antiemetics | 173/240 (72%) | 172/343 (50%) | <.0001 | 146/198 (74%) | 27/42 (64%) | .26 | |
Opiate analgesics | 145/240 (60%) | 204/343 (59%) | .82 | 114/198 (58%) | 31/42 (71%) | .06 | |
Neuropathic pain modulators | 101/240 (42%) | 77/343 (22%) | <.0001 | 82/198 (41%) | 19/42 (45%) | .73 | |
Laxatives | 36/75 (48%) | 51/141 (36%) | .09 | 22/48 (46%) | 14/27 (52%) | .64 |
PAGI-SYM, Patient Assessment of Upper Gastrointestinal Disorders Symptoms.